Allegra sleep artist

All new levels will become effective on the date specified within the related legislation. All specimens identified as positive on the initial tests shall be confirmed using a second test. A gas chromatography/mass spectrometry (GC/MS) test, or an equivalent or more accurate scientifically accepted method approved by the State or Federal government will be used for the confirmation test for narcotics. The confirmation test for alcohol will be gas chromatography. All confirmations shall be done by quantitative analysis. When confirming initial results, all levels equal to or exceeding the following shall be reported as positive: Alcohol . 05g% (by blood) Amphetamines 500 ng/ml allegra sleep artist Cannabinoids 15 ng/ml Cocaine 150 ng/ml Phencyclidine 25 ng/ml Methaqualone 150 ng/ml Opiates 300 ng/ml Barbiturates 150 ng/ml Benzodiazepines 150 ng/ml Methadone 150 ng/ml Propoxyphene 150 ng/ml These levels will remain in effect until such time as they are revised by Federal Legislation or State Statute. All new levels will become effective on the date specified within the related legislation. The laboratory shall report test results to a medical review officer (MRO) chosen by the District to act on its behalf. These results shall be reported within seven (7) working days after receipt of the specimen by the laboratory. The allegra sleep artist laboratory shall transmit results to the medical review officer (MRO) in a manner designed to ensure confidentiality of the information. All records pertaining to a given specimen shall be retained by the laboratory allegra sleep artist for a minimum of two (2) years, unless the District or the employee requests that records be retained for a longer period of time. Within five (5) working days after receipt of a confirmed positive test result from the medical review officer (MRO), the Human Resources allegra sleep artist Office shall inform the employee in writing of allegra sleep artist such positive test result, the consequences of such result, and the options available to allegra sleep artist the employee. Notification shall be via certified mail or hand-delivered. Absent extenuating circumstances, mailed allegra sleep artist notification shall be deemed received by the employee when signed for, or seven (7) calendar days after delivery, whichever occurs first. A copy of allegra sleep artist the test results will be provided to the employee with this notification. Within five (5) working days allegria bridal store after receiving notice of a confirmed allegra sleep artist positive test result from the Human allegra sleep artist Resources Office, the employee may submit information to the Human Resources Office explaining or contesting the test results and why the results do not constitute a violation allegra gray excellent women of this program. The employee will be notified in writing if the explanation or challenge is unsatisfactory to the District. This notice will be hand-delivered or allegro bus qgp 2010 delivered via certified mail within fifteen (15) days of receipt of the employee's explanation or challenge and will state why the employee's explanation is unsatisfactory. All such documentation will be kept confidential and will be retained for at least one (1) year. An employee may make a legal challenge pursuant to Statute or appeal employment decisions made pursuant to this program in accordance with Chapter 20: Appeals Policy of these Regulations.

When an employee initiates the appeal process, it shall be the employee's responsibility to notify the Human Resources Manager and the laboratory in writing that such an appeal has been filed, reference allegra sleep artist the chain of custody specimen identification number and request that the sample be retained by the laboratory until final disposition of the appeal. Retest: During the 180 day period following the employee's receipt of a positive test result, the employee may request that a portion of the original specimen be retested, at the employee's expense.

The retesting must be done at a State licensed or National Institute of Drug allegra sleep artist Abuse (NIDA) approved laboratory other than the original testing facility, and must be allegra sleep artist tested at equal or greater sensitivity for the drug in question as the first. Any employee who feels that (s)he has an addiction to, dependence upon, or developed a problem with alcohol or drugs, legal or illegal, is encouraged to seek assistance. Employees may seek such assistance from the District-sponsored Employee Assistance Program (EAP) or other community resources. Rehabilitation is the responsibility of the employee. Any employee seeking medical attention for alcohol misuse or drug abuse will be entitled to benefits only to the extent specified under the District's group health insurance program and employee assistance program (EAP).

Employees required to be absent from the workplace while in treatment may request a medical leave of absence in accordance with Chapter 18 (Leaves of Absence) of these Regulations. An employee shall be permitted to utilize all available accumulated paid leave before being placed in a leave without pay status.